Tag Archives: YORW

Hot Medical Stocks To Invest In 2019

Shares of Suven Life Sciences touched 52-week high of Rs 267, rising 3.5 percent intraday Thursday as company secured product and process patents in Canada and USA.

The company has been granted 1 product patent from Canada and 1 process patent from USA corresponding to the new chemical entities for the treatment of disorders associated with Neurodegenerative diseases and patents are valid through 2034.

Venkat Jasti, CEO of Suven Life Sciences said, “We are very pleased by the grant of these patents to Suven for our pipeline of molecules in CNS arena that are being developed for cognitive disorders with high unmet medical need with huge market potential globally.”

At 11:50 hrs Suven Life Sciences was quoting at Rs 264.40, up Rs 6.40, or 2.48 percent on the BSE.

Hot Medical Stocks To Invest In 2019: PowerShares DWA Technology Momentum ETF (PTF)

Advisors’ Opinion:

  • [By Stephan Byrd]

    News headlines about PowerShares Dynamic Tech Sec (NASDAQ:PTF) have been trending somewhat positive this week, Accern Sentiment reports. Accern identifies negative and positive news coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. PowerShares Dynamic Tech Sec earned a daily sentiment score of 0.15 on Accern’s scale. Accern also gave media headlines about the company an impact score of 48.5554072096128 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Hot Medical Stocks To Invest In 2019: Hanesbrands Inc.(HBI)

Advisors’ Opinion:

  • [By Timothy Green]

    Basic apparel and activewear manufacturer Hanesbrands (NYSE:HBI) didn’t disappoint when it reported its fourth-quarter results Thursday morning. Strong organic sales growth, driven by its Champion brand of activewear and its international business, led to margin improvements and earnings growth, excluding the effects of a higher tax rate. Hanesbrands easily beat analyst estimates for both revenue and earnings, and its revenue guidance was ahead of expectations.

  • [By Stephan Byrd]

    Morgan Stanley increased its position in shares of Hanesbrands Inc. (NYSE:HBI) by 13.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,095,675 shares of the textile maker’s stock after acquiring an additional 362,960 shares during the period. Morgan Stanley owned about 0.86% of Hanesbrands worth $68,166,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By John Ballard]

    Shares of Hanesbrands (NYSE:HBI) climbed 24% in value last month, according to data provided by S&P Global Market Intelligence.

    Investors got excited about the company’s turnaround efforts when it issued a better-than-expected fourth-quarter earnings report in early February.

Hot Medical Stocks To Invest In 2019: National Health Investors, Inc.(NHI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on National Health Investors (NHI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribers]

    National Health Investors Inc  (NYSE:NHI)Q4 2018 Earnings Conference CallFeb. 19, 2019, 12:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Colleen Schaller — Director, Investor Relations

  • [By Shane Hupp]

    Virginia Retirement Systems ET AL lifted its position in shares of National Health Investors, Inc. (NYSE:NHI) by 10.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 116,300 shares of the real estate investment trust’s stock after acquiring an additional 10,700 shares during the period. Virginia Retirement Systems ET AL owned approximately 0.28% of National Health Investors worth $7,826,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Stephan Byrd]

    Shares of National Health Investors, Inc. (NYSE:NHI) have received a consensus rating of “Hold” from the thirteen analysts that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and four have issued a buy rating on the company. The average 12-month price target among brokerages that have covered the stock in the last year is $71.43.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on National Health Investors (NHI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Medical Stocks To Invest In 2019: J.B. Hunt Transport Services Inc.(JBHT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Rhumbline Advisers grew its position in shares of J B Hunt Transport Services Inc (NASDAQ:JBHT) by 7.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 194,057 shares of the transportation company’s stock after purchasing an additional 13,292 shares during the period. Rhumbline Advisers owned 0.18% of J B Hunt Transport Services worth $23,588,000 at the end of the most recent quarter.

  • [By ]

    In the Lightning Round, Cramer was bullish on T-Mobile US (TMUS) , Lennar (LEN) , Toll Brothers (TOL) , Tyson Foods (TSN) , JB Hunt Transport Services (JBHT) and International Paper (IP) .

  • [By Garrett Baldwin]

    The ongoing trade rift between the United States and China continues to plague international markets. Despite reports that both countries are working behind the scenes to prevent additional detrimental trade policies, both countries recently proposed tens of billions in new tariffs on one another. The United States has accused China of widespread intellectual property theft, while China has accused the United States of unfair trade practices, including price manipulation in the agricultural industry. This morning, it’s worth noting that proposed tariffs on U.S. business jets will likely not provide a competitive advantage to foreign competition. Reuters reports that Chinese aviation executives do not see the layer of protectionism as a way to bolster the nation’s local market. Check back to Money Morning today for more insight on how the ongoing trade war could affect your investments.
    Finally, investors will continue to monitor ongoing developments in Washington around the presidency of Donald Trump. The White House has asked a federal judge to block prosecutors from reviewing any files seized from his lawyer’s office during a raid by the FBI last week. The agency seized a trove of documents from lawyer Michael Cohen’s office as part of an investigation into a payment of hush money. The spat between the White House and the FBI continues a day after former FBI Director James Comey called Trump “morally unfit to be president.”
    Three Stocks to Watch Today: BAC, NFLX, AAPL
    Shares of Bank of America Corp. (NYSE: BAC) added nearly 1% after the nation’s largest bank by deposits topped Wall Street earning expectations. The financial institution leads a busy day of earnings reports on Wall Street and hopes to keep its positive momentum from previous quarters. The firm reported earnings per share of $0.62 on top of $23.27 billion in revenue. That topped expectations of $0.59 on top of $22.91 billion thanks to strong growth in its consumer loan business and the r

  • [By ]

    JB Hunt Transport Services (JBHT) : “I’m sticking with it.”

    Opko Health (OPK) : “I’ve been waiting for these guys to come back on the show and tell us why we should buy.”

  • [By ]

    But then there’s the little-known trucking company JB Hunt (JBHT) , which popped 6.1% because the company saw some surprise growth that no one was expecting. That news was so strong, FedEx (FDX) and XPO Logistics (XPO) also rose 2.2% and 4.6%.

Hot Medical Stocks To Invest In 2019: The York Water Company(YORW)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BidaskClub downgraded shares of York Water (NASDAQ:YORW) from a hold rating to a sell rating in a research report report published on Thursday.

    Separately, Hilliard Lyons raised shares of York Water from an underperform rating to a neutral rating in a research report on Thursday, March 8th.

  • [By Logan Wallace]

    York Water (NASDAQ:YORW) was upgraded by equities research analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research note issued to investors on Saturday.

  • [By Max Byerly]

    PENNON GRP PLC/ADR (OTCMKTS:PEGRY) and York Water (NASDAQ:YORW) are both utilities companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk and valuation.

Top 10 Low Price Stocks To Buy For 2019

A few weeks ago, we published an article that characterized Gilead (GILD) as a “Value Trap.” That article was a follow-up to an earlier article which used our work on Gilead as an example of how a solid conceptual framework could help investors make better decisions. Both of these articles were based on a 16-page valuation report on Gilead we published to our members in September, 2016.

We caught a lot of flack for the recent characterization of Gilead as a value trap, but our opinion was redeemed on February 7th, when the stock fell heavily after a disappointing earnings announcement.

In today’s article, we’ll take another look at the valuation process – the most important weapon in an investor’s arsenal – in a continuation of the Gilead example. We would invite new readers to read through each of the earlier articles as well, to get a picture of the overall process!

Investing Anecdotes are Dangerous!

What interested us in September 2016, when we made our original analysis of Gilead, was the noise among the value investing community about what a deal Gilead was because the stock was trading at such a low Price-to-Earnings (P/E) ratio (See our article Three Things You Should Know About Gilead).

Top 10 Low Price Stocks To Buy For 2019: USG Corporation(USG)

Advisors’ Opinion:

  • [By Ethan Ryder]

    USG Co. (NYSE:USG) – Equities research analysts at SunTrust Banks reduced their Q3 2018 earnings per share estimates for shares of USG in a report issued on Monday, July 9th. SunTrust Banks analyst K. Hughes now forecasts that the construction company will post earnings of $0.57 per share for the quarter, down from their previous estimate of $0.61. SunTrust Banks currently has a “Hold” rating and a $44.00 price target on the stock. SunTrust Banks also issued estimates for USG’s FY2018 earnings at $2.05 EPS, Q3 2019 earnings at $0.71 EPS and FY2019 earnings at $2.53 EPS.

  • [By Stephan Byrd]

    ValuEngine upgraded shares of USG (NYSE:USG) from a buy rating to a strong-buy rating in a report published on Tuesday.

    A number of other research analysts have also recently weighed in on the stock. Credit Suisse Group upgraded shares of USG from an underperform rating to a neutral rating and dropped their target price for the company from $35.00 to $24.00 in a research note on Friday, April 27th. Jefferies Group reiterated a hold rating and issued a $40.00 target price on shares of USG in a research note on Monday, April 23rd. SunTrust Banks boosted their target price on shares of USG from $42.00 to $44.00 and gave the company a hold rating in a research note on Tuesday, April 17th. Buckingham Research boosted their target price on shares of USG from $34.00 to $42.00 and gave the company a neutral rating in a research note on Monday, April 16th. Finally, Nomura boosted their target price on shares of USG from $39.00 to $44.00 and gave the company a neutral rating in a research note on Tuesday, March 27th. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of Hold and an average price target of $39.00.

  • [By Jason Hall, George Budwell, and Chuck Saletta]

    And while it may not always work out well to simply copy the moves other investors make, it can pay off to use their buying and selling moves as jumping-off points in your own research. We asked three real-world investors for their insight, and they wrote about two recent Buffett buys ofApple Inc.(NASDAQ:AAPL) andUSG Corporation(NYSE:USG), and a recent Baker Brothers buy ofHeron Therapeutics Inc(NASDAQ:HRTX).

  • [By Jordan Wathen]

    As USG Corporation (NYSE:USG) drags its feet on an offer to sell the company for $42 per share, Berkshire intends to use its 30.8% ownership stake to motivate its top brass to make a deal. Berkshire told Bloomberg it intends to vote its shares against USG’s board members who are up for re-election at this year’s annual meeting, a clear message that Buffett is ready to cash in, even if USG’s management and board are not.

  • [By Dan Caplinger]

    Warren Buffett likes to hold his stock positions for the long run, and his experience with USG (NYSE:USG) has been typical of his other long-term investments. The Oracle of Omaha started buying shares of the manufacturer of Sheetrock drywall and other building materials back in 2000, accumulating a sizable stake that has ballooned to more than 30% of the company. USG ended up going through bankruptcy in order to get a handle on its asbestos liability claims, but thanks largely to Buffett’s involvement, the building materials company not only survived bankruptcy but also saw share prices soar briefly on hopes that USG would once again fully participate in the then-strong housing boom.

Top 10 Low Price Stocks To Buy For 2019: Tekla Healthcare Opportunies Fund(THQ)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Tekla Healthcare Opportunities Fund (NYSE:THQ) declared a monthly dividend on Monday, June 11th, Wall Street Journal reports. Investors of record on Wednesday, June 20th will be paid a dividend of 0.1125 per share on Friday, June 29th. This represents a $1.35 dividend on an annualized basis and a dividend yield of 7.72%. The ex-dividend date of this dividend is Tuesday, June 19th.

Top 10 Low Price Stocks To Buy For 2019: Ampco-Pittsburgh Corporation(AP)

Advisors’ Opinion:

  • [By ]

    New York (AP) — Four more deaths have been linked to a national food poisoning outbreak blamed on tainted lettuce, bringing the total to five.

    Health officials have tied the E. coli outbreak to romaine lettuce grown in Yuma, Arizona. The growing season there ended six weeks ago, and it's unlikely any tainted lettuce is still in stores or people's homes, given its short shelf life. But there can be a lag in reporting, and reports of illnesses have continued to come in.

  • [By ]

    Cayce, S.C. (AP) — A crash between an Amtrak passenger train and a CSX freight train in South Carolina has left at least two people dead and more than 50 injured

  • [By ]

    Wellington, New Zealand (AP) — New Zealand plans to slaughter about 150,000 cows as it tries to eradicate a strain of disease-causing bacteria from the national herd.

  • [By Shane Hupp]

    Deutsche Bank AG boosted its holdings in Ampco-Pittsburgh Corp (NYSE:AP) by 117.3% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 19,599 shares of the industrial products company’s stock after purchasing an additional 10,578 shares during the quarter. Deutsche Bank AG’s holdings in Ampco-Pittsburgh were worth $242,000 at the end of the most recent quarter.

  • [By ]

    Phoenix (AP) — The classified advertising site Backpage.com ignored warnings to stop running advertisements promoting prostitution, sometimes involving children, because the lucrative enterprise brought in half a billion dollars, according to an indictment unsealed Monday.

Top 10 Low Price Stocks To Buy For 2019: BGC Partners, Inc.(BGCP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on BGC Partners (BGCP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    DEUTSCHE BOERSE/ADR (OTCMKTS: DBOEY) and BGC Partners (NASDAQ:BGCP) are both finance companies, but which is the better business? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.

  • [By ]

    BGC Partners (BGCP) : “We’re in a market where Goldman Sachs (GS) got slammed. I’m going with them.”

    Ecolab (ECL) : “That’s a terrific situation that I want you to buy more of if it comes down.”

  • [By ]

    Cramer was bearish on BGC Partners (BGCP) , Dr Pepper Snapple (DPS) , Sterling Construction Co. Inc.  (STRL) and B&G Foods (BGS) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Logan Wallace]

    LPL Financial (NASDAQ: LPLA) and BGC Partners (NASDAQ:BGCP) are both mid-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, earnings, dividends and profitability.

  • [By Ethan Ryder]

    UBS Group AG raised its holdings in shares of BGC Partners, Inc. (NASDAQ:BGCP) by 248.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,519,131 shares of the financial services provider’s stock after purchasing an additional 1,082,829 shares during the quarter. UBS Group AG’s holdings in BGC Partners were worth $20,432,000 as of its most recent SEC filing.

Top 10 Low Price Stocks To Buy For 2019: The York Water Company(YORW)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BidaskClub downgraded shares of York Water (NASDAQ:YORW) from a hold rating to a sell rating in a research report report published on Thursday.

    Separately, Hilliard Lyons raised shares of York Water from an underperform rating to a neutral rating in a research report on Thursday, March 8th.

Top 10 Low Price Stocks To Buy For 2019: bluebird bio, Inc.(BLUE)

Advisors’ Opinion:

  • [By Brian Orelli]

    On Friday evening, bluebird bio (NASDAQ:BLUE) and Celgene (NASDAQ:CELG) will kick things off with their BCMA-targeted CAR T, bb2121, for patients with multiple myeloma who have failed other treatments. The results from the phase I trial have been impressive so far, albeit in a limited number of patients. The new data should include the expansion cohort of patient treated at the dose to be used in later-stage trials.

  • [By Stephan Byrd]

    bluebird bio (NASDAQ:BLUE) was up 0% during mid-day trading on Thursday . The stock traded as high as $190.50 and last traded at $189.30. Approximately 892,250 shares traded hands during mid-day trading, an increase of 14% from the average daily volume of 779,838 shares. The stock had previously closed at $189.30.

  • [By Ethan Ryder]

    Blue Protocol (CURRENCY:BLUE) traded 5.2% lower against the US dollar during the one day period ending at 18:00 PM ET on June 27th. In the last seven days, Blue Protocol has traded down 29.4% against the US dollar. Blue Protocol has a total market capitalization of $3.16 million and approximately $3,034.00 worth of Blue Protocol was traded on exchanges in the last 24 hours. One Blue Protocol token can currently be bought for approximately $0.0862 or 0.00001406 BTC on exchanges including IDEX, YoBit, CoinExchange and EtherDelta (ForkDelta).

  • [By Motley Fool Staff]

    In his fourth segment — something blue — he talks about clinical-stage gene-therapy company bluebird bio(NASDAQ:BLUE). It’s a RuleBreakers recommendation, and it has been for almost three and a half years. It’s also a fine illustration of some key Foolish principles of investing.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Brian Orelli]

    bluebird bio (NASDAQ:BLUE) reportedfirst-quarter earnings last week, but like the biotech typically does, management didn’t hold a conference call, which makes the earnings release more of a rehash of the quarter than an actual update.

Top 10 Low Price Stocks To Buy For 2019: Cabot Corporation(CBT)

Advisors’ Opinion:

  • [By Logan Wallace]

    Scopus Asset Management L.P. lifted its position in shares of Cabot Corp (NYSE:CBT) by 74.0% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 435,000 shares of the specialty chemicals company’s stock after buying an additional 185,000 shares during the quarter. Scopus Asset Management L.P.’s holdings in Cabot were worth $24,238,000 at the end of the most recent quarter.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Hertz Global Holdings, Inc. (NYSE: HTZ) is projected to post quarterly loss at $1.31 per share on revenue of $1.97 billion.
    International Flavors & Fragrances Inc. (NYSE: IFF) is estimated to post quarterly earnings at $1.59 per share on revenue of $909.36 million.
    Zillow Group, Inc. (NASDAQ: ZG) is expected to post quarterly earnings at $0.06 per share on revenue of $294.79 million.
    General Cable Corporation (NYSE: BGC) is estimated to post quarterly earnings at $0.15 per share on revenue of $980.61 million.
    Central Garden & Pet Company (NASDAQ: CENT) is expected to post quarterly earnings at $0.84 per share on revenue of $598.45 million.
    Cabot Corporation (NYSE: CBT) is estimated to post quarterly earnings at $1 per share on revenue of $746.42 million.
    Fabrinet (NYSE: FN) is expected to post quarterly earnings at $0.71 per share on revenue of $319.71 million.
    National General Holdings Corp. (NASDAQ: NGHC) is projected to post quarterly earnings at $0.55 per share on revenue of $1.08 billion.
    The Navigators Group, Inc. (NASDAQ: NAVG) is estimated to post quarterly earnings at $0.75 per share on revenue of $320.92 million.
    Diplomat Pharmacy, Inc. (NYSE: DPLO) is expected to post quarterly earnings at $0.22 per share on revenue of $1.29 billion.
    Trex Company, Inc. (NYSE: TREX) is projected to post quarterly earnings at $1.19 per share on revenue of $172.22 million.
    AMC Entertainment Holdings, Inc. (NYSE: AMC) is expected to post quarterly earnings at $0.09 per share on revenue of $1.35 billion.
    Envision Healthcare Corporation (NYSE: EVHC) is projected to post quarterly earnings at $0.64 per share on revenue of $2.02 billion.
    Regal Beloit Corporation (NYSE: RBC) is estimated to post quarterly earnings at $1.23 per share on revenue of $869.64 million.
    Amedisys, Inc. (NASDAQ: AMED) is projected to post quarterly earnings at $0.67 per share on revenue of $39

  • [By Joseph Griffin]

    Sei Investments Co. increased its position in shares of Cabot Corp (NYSE:CBT) by 137.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 69,527 shares of the specialty chemicals company’s stock after acquiring an additional 40,219 shares during the quarter. Sei Investments Co. owned approximately 0.11% of Cabot worth $3,874,000 as of its most recent filing with the Securities and Exchange Commission.

Top 10 Low Price Stocks To Buy For 2019: T-Mobile US, Inc.(TMUS)

Advisors’ Opinion:

  • [By Adam Levy]

    AT&T hopes its bundle can differentiate its product from competitors like Verizon (NYSE:VZ) and T-Mobile (NASDAQ:TMUS), and improve its customer retention. But as it adds more options to the bundle, it could deteriorate its margins without providing meaningful value to many customers.

  • [By ]

    Over on Real Money, Cramer talks about how to trade the highly unlikely deal between Sprint (S) and T-Mobile (TMUS) . Get more of his insights with a free trial subscription to Real Money.

  • [By Paul Ausick]

    The margins for wireless carriers have frayed as Sprint Corp. (NYSE: S), T-Mobile US Inc. (NASDAQ: TMUS), Verizon Communications Inc. (NYSE: VZ) and AT&T play for position among customers in a saturated market. The iPhone 8 still gives them a chance to go after one another with a new chess piece.

  • [By Daniel B. Kline]

    While Sprint (NYSE:S) has an all-stock deal in place to merge with T-Mobile (NASDAQ:TMUS), there are significant doubts that federal regulators will approve it. If that happens, T-Mobile will go back to its fight against Verizon (NYSE:VZ) and AT&T (NYSE:T), with perhaps some added maverick credibility.

Top 10 Low Price Stocks To Buy For 2019: Bovie Medical Corporation(BVX)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results.
    Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88.
    Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results.
    Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat.
    Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results.
    LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results.
    ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results.
    Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    MYnd
  • [By Ethan Ryder]

    TheStreet upgraded shares of Bovie Medical (NYSEAMERICAN:BVX) from a d rating to a c- rating in a research report report published on Monday morning.

  • [By Lisa Levin] Gainers
    Red Violet, Inc. (NASDAQ: RDVT) rose 75.31 percent to close at $9.94 after reporting Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 40.62 percent to close at $4.50 on Tuesday after reporting 2017 year-end results.
    MEI Pharma, Inc. (NASDAQ: MEIP) gained 34.39 percent to close at $3.40.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) gained 32.74 percent to close at $1.50 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Pfenex Inc. (NYSE: PFNX) surged 31.15 percent to close at $8.00 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) rose 21.07 percent to close at $11.09. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Genprex, Inc. (NASDAQ: GNPX) rose 20.23 percent to close at $10.58.
    Turtle Beach Corporation (NASDAQ: HEAR) shares gained 17.62 percent to close at $17.82.
    Aptevo Therapeutics Inc. (NASDAQ: APVO) rose 17.1 percent to close at $5.82.
    Phoenix New Media Limited (NYSE: FENG) shares jumped 16.23 percent to close at $4.87 following Q1 earnings.
    Stein Mart, Inc. (NASDAQ: SMRT) rose 16.04 percent to close at $3.69.
    PPDAI Group Inc. (NASDAQ: PPDF) climbed 15.99 percent to close at $7.98 following Q1 results.
    Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.93 percent to close at $3.42.
    LiqTech International, Inc. (NASDAQ: LIQT) gained 15.59 percent to close at $0.5532 following Q1 results.
    Sophiris Bio, Inc. (NASDAQ: SPHS) gained 13.92 percent to close at $3.52 on Tuesday following Q1 results.
    Euroseas Ltd. (NASDAQ: ESEA) jumped 13.4 percent to close at $2.37.
    Iteris, Inc. (NASDAQ: ITI) shares surged 13.05 percent to close
  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results.
    LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat.
    MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results.
    Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat.
    Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday.
    Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday.
    PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results.
    Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy.
    Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat.
    Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o

Top 10 Low Price Stocks To Buy For 2019: Gladstone Commercial Corporation(GOOD)

Advisors’ Opinion:

  • [By Max Byerly]

    Goodomy (GOOD) is a PoW/PoS token that uses the Scrypt hashing algorithm. Its genesis date was June 21st, 2017. Goodomy’s total supply is 888,000,000 tokens and its circulating supply is 620,508,777 tokens. Goodomy’s official Twitter account is @GoodKarmaCoin and its Facebook page is accessible here. Goodomy’s official website is goodomy.com.

  • [By Shane Hupp]

    Goodomy (GOOD) is a PoW/PoS token that uses the Scrypt hashing algorithm. Its launch date was June 21st, 2017. Goodomy’s total supply is 888,000,000 tokens and its circulating supply is 620,508,777 tokens. Goodomy’s official Twitter account is @GoodKarmaCoin and its Facebook page is accessible here. Goodomy’s official website is goodomy.com.

Top 10 Casino Stocks To Watch Right Now

“Real estate is an imperishable asset ever increasing in value. It is the most solid security that human ingenuity has devised.” — Russell Sage

Walt Disney (1901-66), the singular visionary genius who — more than anyone — transformed the business of entertainment in the 20th century, had legions of admirers over the decades. Among them is Steve Wynn, founder, CEO and guiding mastermind of his eponymous casino empire. In both public and private statements, Wynn has pointed to Disney’s core insight into the fine art of delighting consumers as what drives the management culture of his company until this day.

But for all his prescient brilliance, Disney did not fully apprehend the shower of millions his Disneyland theme park would have on the properties surrounding the Anaheim project. Neither did the very savvy Harrison Price of the Stamford Research Institute, who Disney commissioned to pick out the best possible location for his first theme park.

He acquired 160 acres of orange groves and walnut trees in the then-sleepy Orange County suburb of Anaheim, believing it would provide a huge enough footprint upon which to build his dream. And it did. What he didn’t really grasp was that the nearby land could still be picked up cheap if you were either a speculator or a motel company foreseeing more than day-trippers visiting the park. As a result, no sooner than Disneyland opened in July 1955 was the area blotted with construction projects for motels, hotels, restaurants and shopping centers whose primary claim to financial viability sprung from their proximity to Disneyland. Walt watched the parasite property owners grow rich and vowed never to repeat the mistake. And he didn’t.

Top 10 Casino Stocks To Watch Right Now: NetApp Inc.(NTAP)

Advisors’ Opinion:

  • [By Taylor Cox]

    Notable Earnings

    Tiffany & Co. (NYSE: TIF) Q1 premarket
    Ralph Lauren Corporation (NYSE: RL) Q4 premarket
    Target Corporation (NYSE: TGT) Q1 premarket
    Lowe’s Companies, Inc (NYSE: LOW) Q1 premarket
    L Brands, Inc (NYSE: LB) Q1 after hours
    NetApp, Inc (NASDAQ: NTAP) Q4 after hours

    IPOs

  • [By Stephan Byrd]

    Profund Advisors LLC lifted its stake in shares of NetApp Inc. (NASDAQ:NTAP) by 14.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 9,660 shares of the data storage provider’s stock after purchasing an additional 1,193 shares during the period. Profund Advisors LLC’s holdings in NetApp were worth $596,000 at the end of the most recent quarter.

  • [By Jon C. Ogg]

    NetApp Inc. (NASDAQ: NTAP) was reiterated as Buy and the price target was raised to $90 from $76 at Argus. The firm noted that new offerings with Cisco in the FlexPod solutions have a big jump in health care and the firm came up with a blended analysis of earnings and valuation that could be north of $100 for the stock.

  • [By Lee Jackson]

    NetApp Inc. (NASDAQ: NTAP) was added to US 1 list earlier this yearand has been on big run since last fall.The company provides software, systems and services to manage and store computer data worldwide. It offers flash; flash arrays that support data management; hybrid arrays to deploy the speed of flash storage; hybrid cloud; ONTAP cloud storage data management service; NetApp cloud sync hybrid data management software as a service; NetApp private storage for cloud; and AltaVault cloud-integrated solutions.

Top 10 Casino Stocks To Watch Right Now: TransAct Technologies Incorporated(TACT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Logitech (NASDAQ: LOGI) and TransAct Technologies (NASDAQ:TACT) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability.

Top 10 Casino Stocks To Watch Right Now: The York Water Company(YORW)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BidaskClub downgraded shares of York Water (NASDAQ:YORW) from a hold rating to a sell rating in a research report report published on Thursday.

    Separately, Hilliard Lyons raised shares of York Water from an underperform rating to a neutral rating in a research report on Thursday, March 8th.

Top 10 Casino Stocks To Watch Right Now: Perficient, Inc.(PRFT)

Advisors’ Opinion:

  • [By Shane Hupp]

    Perficient (NASDAQ:PRFT) was downgraded by investment analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a research note issued on Friday.

Top 10 Casino Stocks To Watch Right Now: Cellcom Israel Ltd.(CEL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Natural Health Trends Corp (NASDAQ: NHTC) fell 7.8 percent to $19.80 in pre-market trading after rising 1.46 percent on Friday.
    Endocyte, Inc. (NASDAQ: ECYT) shares fell 6.6 percent to $11.41 in pre-market trading after climbing 4.18 percent on Friday.
    Quorum Health Corporation (NYSE: QHC) shares fell 6.2 percent to $5.15 in pre-market trading after tumbling 11.45 percent on Friday.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) fell 6.1 percent to $7.31 in pre-market trading after declining 3.35 percent on Friday.
    Boston Scientific Corporation (NYSE: BSX) fell 5.6 percent to $28.30 in pre-market trading.
    Evofem Biosciences, Inc. (NASDAQ: EVFM) fell 5.3 percent to $6.06 in pre-market trading after gaining 2.73 percent on Friday.
    Xerox Corporation (NYSE: XRX) shares fell 5.2 percent to $28.60 in pre-market trading. Xerox terminated its transaction agreement with Fujifilm and entered into a new agreement with Carl Icahn and Darwin Deason. JP Morgan downgraded Xerox from Overweight to Neutral.
    Cellcom Israel Ltd. (NYSE: CEL) fell 5.2 percent to $7.02 in pre-market trading. Cellcom is expected to release Q1 results on May 30, 2018.
    Perrigo Company plc (NYSE: PRGO) fell 4.5 percent to $74 in pre-market trading.
    Nabriva Therapeutics plc (NASDAQ: NBRV) shares fell 4 percent to $4.66 in pre-market trading

  • [By Lisa Levin]

    Thursday afternoon, the health care shares rose 1.79 percent. Meanwhile, top gainers in the sector included Partner Communications Company Ltd. (NASDAQ: PTNR), up 8 percent, and Cellcom Israel Ltd. (NYSE: CEL) up 7 percent.

  • [By Ethan Ryder]

    Millicom (OTCMKTS: MIICF) and Cellcom Israel (NYSE:CEL) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

  • [By Lisa Levin]

    Thursday afternoon, the telecommunication services shares surged 0.58 percent. Meanwhile, top gainers in the sector included Intelsat S.A. (NYSE: I), up 5 percent, and Cellcom Israel Ltd. (NYSE: CEL) up 2.5 percent.

Top 10 Casino Stocks To Watch Right Now: GlaxoSmithKline PLC(GSK)

Advisors’ Opinion:

  • [By Keith Speights]

    If you only looked at stock performance for 2018, GlaxoSmithKline plc (NYSE:GSK) would seem to be in much better shape than AbbVie Inc. (NYSE:ABBV). GSK stock is up nearly 20% year to date, while AbbVie’s share price isn’t much higher than it was at the beginning of the year. 2017 was a different story, though, with AbbVie gaining more than 50% and GSK falling 8%.

  • [By Cory Renauer]

    Around a year ago, the partners launched an eczema drug that’s already surpassed Praluent on the sales charts, and a possible expansion to asthma could send Dupixent sales through the roof.In studies supporting an application under review at the moment, Dupixent reduced severe attacks by up to 67% for some patients with uncontrolled asthma. It also led to lung function measurements that suggest it can compete with GlaxoSmithKline’s (NYSE:GSK)Nucula for a slice of a global market for asthma treatments expected to reach $56.5 billion by 2025.

  • [By Ethan Ryder]

    GlaxoSmithKline plc (NYSE:GSK) was the target of a large drop in short interest during the month of May. As of May 31st, there was short interest totalling 8,497,397 shares, a drop of 27.2% from the May 15th total of 11,675,520 shares. Based on an average daily volume of 2,406,543 shares, the short-interest ratio is currently 3.5 days.

  • [By Keith Speights]

    GlaxoSmithKline (GSK), like Teva, lost ground last year, with its stock declining by nearly 8%. So far in 2018, though, GSK’s share price is up more than 12% — trouncing the major indexes.

  • [By Sean Williams]

    Lastly, there’s Innoviva (NASDAQ:INVA), which isn’t a traditional drug stock, per se. Innoviva is a royalty company that’s currently reaping benefits from a group of long-lasting COPD and asthma medications that were developed in cooperation with GlaxoSmithKline (NYSE:GSK). You know these medicines today as Breo Ellipta and Anoro Ellipta, to name a few.

Top 10 Casino Stocks To Watch Right Now: Silicom Ltd(SILC)

Advisors’ Opinion:

  • [By Joseph Griffin]

    F5 Networks (NASDAQ: FFIV) and Silicom (NASDAQ:SILC) are both computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, valuation, dividends, analyst recommendations, earnings and institutional ownership.

  • [By ]

    Finally, Cramer said that Silicom (SILC) is an interesting concept with real earnings, and an attractive valuation at just 18 times earnings. However, the company is small, which mean investors need to be careful. 

Top 10 Casino Stocks To Watch Right Now: Meta Financial Group Inc.(CASH)

Advisors’ Opinion:

  • [By Shane Hupp]

    Cashcoin (CURRENCY:CASH) traded up 40.8% against the dollar during the one day period ending at 16:00 PM E.T. on May 9th. Cashcoin has a market cap of $544,583.00 and $885.00 worth of Cashcoin was traded on exchanges in the last 24 hours. Over the last seven days, Cashcoin has traded up 68.3% against the dollar. One Cashcoin coin can currently be bought for $0.0114 or 0.00000123 BTC on popular exchanges.

  • [By Shane Hupp]

    Cashcoin (CURRENCY:CASH) traded up 0.5% against the US dollar during the one day period ending at 0:00 AM E.T. on June 10th. One Cashcoin coin can currently be purchased for about $0.0079 or 0.00000117 BTC on major cryptocurrency exchanges. Over the last week, Cashcoin has traded down 29.1% against the US dollar. Cashcoin has a market capitalization of $377,649.00 and approximately $114.00 worth of Cashcoin was traded on exchanges in the last 24 hours.

  • [By Stephan Byrd]

    Meta Financial Group Inc. (NASDAQ:CASH) – Equities researchers at B. Riley cut their FY2018 earnings per share (EPS) estimates for Meta Financial Group in a report issued on Tuesday, June 19th. B. Riley analyst S. Moss now forecasts that the savings and loans company will post earnings per share of $6.43 for the year, down from their previous forecast of $6.90. B. Riley currently has a “Buy” rating and a $132.00 price target on the stock. B. Riley also issued estimates for Meta Financial Group’s Q1 2019 earnings at $1.29 EPS and Q2 2019 earnings at $3.46 EPS.

Top 10 Casino Stocks To Watch Right Now: UMH Properties Inc.(UMH)

Advisors’ Opinion:

  • [By Joseph Griffin]

    WINTON GROUP Ltd bought a new stake in UMH PROPERTIES/SH SH (NYSE:UMH) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 86,705 shares of the real estate investment trust’s stock, valued at approximately $1,163,000. WINTON GROUP Ltd owned about 0.24% of UMH PROPERTIES/SH SH as of its most recent SEC filing.

  • [By Lisa Levin]

    Wednesday afternoon, the real estate shares surged 0.56 percent. Meanwhile, top gainers in the sector included Armada Hoffler Properties, Inc. (NYSE: AHH), up 3 percent, and UMH Properties, Inc. (NYSE: UMH) up 3 percent.

Top 10 Casino Stocks To Watch Right Now: Hitachi Ltd (HTHIF)

Advisors’ Opinion:

  • [By ]

    Some of the larger companies that have begun incorporating blockchain into their industries include:

    Overstock.com (OSTK) , once a retail company, has become one of the biggest blockchain options on the stock market. The company has developed tZERO, a cryptocurrency and blockchain-based registry that complies with the regulations of the U.S. Securities & Exchange Commission. IBM (IBM) has developed blockchain technology that they are using with a large variety of partners in a large variety of industries. One example is their partnership with food retailers, most notably Walmart, to help quickly, efficiently, and securely track the supply chain to help ensure ideal food safety. They have also partnered with Maersk to work on a blockchain platform for global trade. Hitachi (HTHIF) , the Japanese conglomerate that has worked on social infrastructure and IT systems, among other industries, has begun dabbling in blockchain. It has released reports about how it believes the technology can positively impact the financial sector, and how it could potentially be used to create new services for businesses.

    There are also ETFs that one can invest in that hold a number of stocks related to blockchain. For example, the Reality Shares Nasdaq NextGen Economy ETF (BLCN) holds stocks in all of the examples above, as well as Intel (INTC) and Cisco Systems (CSCO) .

  • [By ]

    The vast dealer network, built up over the more than 90 years that Caterpillar has been in operation, is the key competitive advantage that the company possesses. While Caterpillar’s products are renowned for quality and low downtime, it is the availability of the support service on an international level in tandem with a reputation for product quality is what gives Caterpillar its edge, and has given it pole position among the world’s construction machinery manufacturers in 2017 based on construction equipment sales, outranking Komatsu Ltd. (OTCPK:KMTUF) (OTCPK:KMTUY), Hitachi Ltd. (OTCPK:HTHIF) (OTCPK:HTHIY), Volvo (OTCPK:VOLVF) (OTCPK:VOLVY), the privately-held Liebherr group, the Chinese government-owned XCMG Group, the Doosan Infracore subsidiary of the Doosan Group conglomerate, Sany (OTCPK:SNYYF) (OTC:SNYYY), and John Deere & Co.

Top Medical Stocks To Own For 2019

Self-described Tesla superfan Matthew Chan always wanted to meet some of the key people behind the electric car maker.

And when the cancer patient’s wish came true this week with a visit to the company’s factory in California, he got even more than he bargained for.

Not only did he go on a tour and meet Tesla’s top car designer, he also came face-to-face with CEO and co-founder Elon Musk.

It all started when Chan’s close friend Alan Miller shared a post on a couple of Tesla (TSLA) forums earlier this month.

“My best friend from medical school, Matthew Chan, is a 39 year old radiologist in Sacramento with 3 kids who was just diagnosed with stage 4 colon cancer,” he wrote.

The post added that Chan, who owns two Teslas, dreamed of meeting JB Straubel, the company’s chief technology officer, and Franz von Holzhausen, its lead designer.

“Of course, I wanted to meet Elon, but I was interested in also talking to the guys who Elon goes to and says, ‘I need this done,'” Chan told CNNMoney in a phone interview Thursday.

Top Medical Stocks To Own For 2019: CryoPort, Inc.(CYRX)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on CryoPort (CYRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Press coverage about CryoPort (NASDAQ:CYRX) has been trending somewhat positive on Monday, according to Accern Sentiment Analysis. Accern identifies positive and negative press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. CryoPort earned a coverage optimism score of 0.05 on Accern’s scale. Accern also gave media coverage about the consumer goods maker an impact score of 46.4366918065987 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

  • [By Ethan Ryder]

    CryoPort (NASDAQ:CYRX) posted its quarterly earnings results on Thursday. The consumer goods maker reported ($0.10) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.07) by ($0.03), Briefing.com reports. The company had revenue of $4.02 million during the quarter, compared to the consensus estimate of $3.84 million. CryoPort had a negative return on equity of 47.36% and a negative net margin of 66.09%. The company’s revenue for the quarter was up 48.3% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.10) earnings per share.

Top Medical Stocks To Own For 2019: PennyMac Mortgage Investment Trust(PMT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Pennymac Mortgage Investment (NYSE:PMT) shares reached a new 52-week high and low on Monday . The company traded as low as $18.60 and last traded at $18.62, with a volume of 19306 shares changing hands. The stock had previously closed at $18.50.

  • [By Stephan Byrd]

    Pennymac Mortgage Investment (NYSE:PMT) – Equities researchers at Wedbush lifted their Q1 2019 earnings per share estimates for shares of Pennymac Mortgage Investment in a research note issued to investors on Thursday, May 10th. Wedbush analyst J. Weaver now anticipates that the real estate investment trust will post earnings per share of $0.36 for the quarter, up from their previous estimate of $0.34. Wedbush also issued estimates for Pennymac Mortgage Investment’s Q2 2019 earnings at $0.43 EPS, Q3 2019 earnings at $0.43 EPS, Q4 2019 earnings at $0.52 EPS and FY2019 earnings at $1.74 EPS.

Top Medical Stocks To Own For 2019: UnitedHealth Group Incorporated(UNH)

Advisors’ Opinion:

  • [By Paul Ausick]

    Before the opening bell Tuesday, Dow Jones Industrial Average component UnitedHealth Group Inc. (NYSE: UNH) is expected to report another solid quarter. After all, the company has beat analysts’ earnings estimate for eight straight quarters and revenues in six of those eight.

  • [By Chris Lange]

    UnitedHealth Group Inc. (NYSE: UNH) is scheduled to share its quarterly report on Tuesday as well. The consensus estimates are $2.91 in EPS on $54.8 billion in revenue. Shares were last seen at $224.28. The stock has a 52-week range of $164.96 to $250.79, and the consensus price target is $271.67.

  • [By JJ Kinahan]

    Going into earnings season, one school of thought was that investors might be concerned more about companies’ forward guidance in some cases than in Q1 results. There was worry that perhaps the recent market turmoil and fears of a possible trade war could dampen some S&P 500 firms’ expectations for what the near future might bring. It’s less than a week since earnings began and guidance could still represent a speed bump in coming weeks, but so far it hasn’t been a problem. For instance, UnitedHealth Group Inc. (NYSE: UNH) raised fiscal year guidance Tuesday, and Johnson & Johnson (NYSE: JNJ) raised its revenue guidance. In other signs of general good cheer, Goldman Sachs Group Inc. (NYSE: GS) raised its quarterly dividend, while Netflix (NFLX) reported big gains in subscriber growth. It’s still really early and things could change, but maybe some of those guidance fears could have been, shall we say, misguided? 

  • [By Paul Ausick]

    The second-best performer among the Dow index equities so far this year is Nike Inc. (NYSE: NKE), which is up 17.39%. That is followed by Microsoft Corp. (NASDAQ: MSFT), up 17.38%, UnitedHealth Group Inc. (NYSE: UNH), up 19.4%, and Boeing Co. (NYSE: BA), up 14.9%. Of the 30 Dow stocks, 11 have managed to post a gain to date in 2018.

  • [By Paul Ausick]

    The Dow stock posting the largest daily percentage gain ahead of the close Monday was UnitedHealth Group Inc. (NYSE: UNH) which traded up 1.67% at $242.25. The stock’s 52-week range is $166.65 to $250.79. Volume was about 15% below the daily average of around 3.5 million shares. The company had no specific news.

Top Medical Stocks To Own For 2019: Natural Health Trends Corp.(NHTC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Natural Health Trends Corp (NASDAQ: NHTC) fell 7.8 percent to $19.80 in pre-market trading after rising 1.46 percent on Friday.
    Endocyte, Inc. (NASDAQ: ECYT) shares fell 6.6 percent to $11.41 in pre-market trading after climbing 4.18 percent on Friday.
    Quorum Health Corporation (NYSE: QHC) shares fell 6.2 percent to $5.15 in pre-market trading after tumbling 11.45 percent on Friday.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) fell 6.1 percent to $7.31 in pre-market trading after declining 3.35 percent on Friday.
    Boston Scientific Corporation (NYSE: BSX) fell 5.6 percent to $28.30 in pre-market trading.
    Evofem Biosciences, Inc. (NASDAQ: EVFM) fell 5.3 percent to $6.06 in pre-market trading after gaining 2.73 percent on Friday.
    Xerox Corporation (NYSE: XRX) shares fell 5.2 percent to $28.60 in pre-market trading. Xerox terminated its transaction agreement with Fujifilm and entered into a new agreement with Carl Icahn and Darwin Deason. JP Morgan downgraded Xerox from Overweight to Neutral.
    Cellcom Israel Ltd. (NYSE: CEL) fell 5.2 percent to $7.02 in pre-market trading. Cellcom is expected to release Q1 results on May 30, 2018.
    Perrigo Company plc (NYSE: PRGO) fell 4.5 percent to $74 in pre-market trading.
    Nabriva Therapeutics plc (NASDAQ: NBRV) shares fell 4 percent to $4.66 in pre-market trading

Top Medical Stocks To Own For 2019: Manitex International Inc.(MNTX)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Manitex International Inc (NASDAQ:MNTX) hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $12.95 and last traded at $12.61, with a volume of 655 shares changing hands. The stock had previously closed at $12.94.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Manitex International (MNTX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Medical Stocks To Own For 2019: The York Water Company(YORW)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BidaskClub downgraded shares of York Water (NASDAQ:YORW) from a hold rating to a sell rating in a research report report published on Thursday.

    Separately, Hilliard Lyons raised shares of York Water from an underperform rating to a neutral rating in a research report on Thursday, March 8th.